Oruka Therapeutics, Inc. ORKA Common Stock Shares Outstanding
Common Stock Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s common stock shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s common stock shares outstanding?
- Oruka Therapeutics, Inc. (ORKA) reported common stock shares outstanding of $160.99M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s common stock shares outstanding changed year-over-year?
- Oruka Therapeutics, Inc.'s common stock shares outstanding increased by 3322.3% year-over-year, from $4.7M to $160.99M.
- What does common stock shares outstanding mean?
- This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.